2020年度论文（SCI收录）
1. Shuai C, Liu G, Yang Y, Qi F, Peng S, Yang W, He C, Wang G, Qian G. A strawberry-like Ag-decorated barium titanate enhances piezoelectric and antibacterial activities of polymer scaffold. Nano Energy. 2020, 74: 104825-18. （IF: 16.602）（彭淑平组）
2. Xie K, Zhang X, Tao Y. Rab22a-NeoF1: a promising target for osteosarcoma patients with lung metastasis. Signal Transduct Target Ther. 2020 Aug 24;5(1):161. PMID: 32839478 （IF: 13.493）（陶永光组）
3. Liu N, Yang R, Shi Y, Chen L, Liu Y, Wang Z, Liu S, Ouyang L, Wang H, Lai W, Mao C, Wang M, Cheng Y, Liu S, Wang X, Zhou H, Cao Y, Xiao D, Tao Y. The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties. Signal Transduct Target Ther. 2020, 5(1): 197. PMID: 32994405 （IF: 13.493）（陶永光组）
4. Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J, Xu H, Jiang X, Wang L. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduct Target Ther. 2020 Oct 23. PMID: 33093441 （IF: 13.493）（任彩萍组）
5. Ouyang L, Yan B, Liu Y, Mao C, Wang M, Liu N, Wang Z, Liu S, Shi Y, Chen L, Wang X, Cheng Y, Cao Y, Xiao D, Zhang L, Liu S, Tao Y. The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor. Signal Transduct Target Ther. 2020,5(1):78. PMID: 32546741 （IF: 13.493）（陶永光组）
6. Chen L, Liu S, Tao Y. Regulating tumor suppressor genes: post-translational modifications. Signal Transduct Target Ther. 2020 Jun 10;5(1):90. PMID: 32532965 （IF: 13.493）（陶永光组）
7. Xie L, Shi F, Li Y, Li W, Yu X, Zhao L, Zhou M, Hu J, Luo X, Tang M, Fan J, Zhou J, Gao Q, Wu W, Zhang X, Liao W, Bode AM, Cao Y. Drp1-dependent remodeling of mitochondrial morphology triggered by EBV-LMP1 increases cisplatin resistance. Signal Transduct Target Ther. 2020 May 20; 5(1):56. PMID: 32433544 （IF: 13.493）（曹亚组）
8. Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, Zhao L, Zhao L, Yu X, Luo X, Liao W, Bode AM. Targeting the signaling in EBV-associated diseases: mechanism, regulation and clinical study. Signal Transduct Target Ther.已接收. PMID: 33436584 （IF: 13.493）（曹亚组）
9. Jian X, Zhu Y, Ouyang J, Wang Y, Lei Q, Xia J, Guan Y, Zhang J, Guo J, He Y, Wang J, Li J, Lin J, Su M, Li G, Wu M, Qiu L, Xiang J, Xie L, Jia W, Zhou W. Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria. Microbiome. 2020,8(1):74. PMID: 32466801 （IF: 11.607）（周文组）
10. Zhang X, Xie K, Zhou H, Wu Y, Li C, Liu Y, Liu Z, Xu Q, Liu S, Xiao D, Tao Y. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance. Mol Cancer. 2020, 19(1):47. PMID: 32122355 （IF: 10.679）（陶永光组）
11. Wu Y, Zhang S, Gong X, Tam S, Xiao D, Liu S, Tao Y. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer. 2020, 19(1):39. PMID: 32103754 （IF: 10.679）（陶永光组）
12. Wang Z, Chen X, Liu N, Shi Y, Liu Y, Ouyang L, Tam S, Xiao D, Liu S, Wen F, Tao Y. A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis. Mol Ther. 已接收. PMID: 33002417 （IF: 8.986）（陶永光组）
13. Hu J, Li Y, Li H, Shi F, Xie L, Zhao L, Tang M, Luo X, Jia W, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Liao W, Bode AM, Cao Y. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy. Theranostics. 2020;10 (26): 11921-11937. PMID: 33204320 （IF: 8.579）（曹亚组）
14. Yu Z, Feng J, Wang W, Deng Z, Zhang Y, Xiao L, Wang Z, Liu C, Liu Q, Chen S, Wu M. The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. Oncogene. 2020;39(15):3163-3178. PMID: 32051553 （IF: 7.971）（武明花组）
15. Feng J, Zhang Y, Ren X, Li D, Fu H, Liu C, Zhou W, Liu Q, Liu Q, Wu M. Leucine-rich repeat containing 4 act as an autophagy inhibitor that restores sensitivity of glioblastoma to temozolomide. Oncogene. 2020 ;39(23):4551-4566. PMID: 32372061 （IF: 7.971）（武明花组）
16. Liu S, Lai W, Shi Y, Liu N, Ouyang L, Zhang Z, Chen L, Wang X, Qian B, Xiao D, Yan Q, Cao Y, Liu S, Tao Y. Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers. NPJ Precis Oncol. 2020 Mar 3;4:5. PMID: 32195358 （IF: 7.700）（陶永光组）
17. Ban Y, Tan P, Cai J, Li J, Hu M, Zhou Y, Mei Y, Tan Y, Li X, Zeng Z, Xiong W, Li G, Li X, Yi M, Xiang B. LNCAROD is Stabilized by m6A Methylation and Promotes Cancer Progression via Forming a Ternary Complex with HSPA1A and YBX2 Proteins in Head and Neck Squamous Cell Carcinoma. Mol Oncol. 2021 Jun;14(6):1282-1296. PMID: 32216017 （IF: 7.574）（向波组）
18. Wu X, Zhou Z, Xu S, Liao C, Chen X, Li B, Peng J, Li D, Yang L. Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling. Cancer Lett. 2020,478:93-106. PMID: 32160975 （IF: 7.360）（杨力芳组）
19. Zhou Z, Zhou Q, Wu X, Xu S, Hu X, Tao X, Li B, Peng J, Li D, Shen L, Cao Y, Yang L. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling. Cancer Lett. 2020,473:62-73. PMID: 31904479 （IF: 7.360）（杨力芳组）
20. Fan C, Qu H, Xiong F, Tang Y, Tang T, Zhang L, Mo Y, Li X, Guo C, Zhang S, Gong Z, Li Z, Xiang B, Deng H, Zhou M, Liao Q, Zhou Y, Li X, Li Y, Li G, Wang F, Zeng Z. CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling. Cancer Lett. 2021 Jan 1;496:41-56. PMID: 32931883 （IF: 7.360）（曾朝阳组）
21. Zhu K, Li P, Mo Y, Wang J, Jiang X, Ge J, Huang W, Liu Y, Tang Y, Gong Z, Liao Q, Li X, Li G, Xiong W, Zeng Z, Yu J. Neutrophils: Accomplices in metastasis. Cancer Lett. 2020 Nov 1;492:11-20. PMID: 32745581 （IF: 7.360）（曾朝阳组）
22. Liu C, Wu Y, Ma J. Interaction of non-coding RNAs and Hippo signaling: Implications for tumorigenesis. Cancer Lett. 2020 Aug 18; 493: 207-216. PMID: 32822816 （IF: 7.360）（马健组）
23. Zhao J, Guo C, Xiong F, Yu J, Ge J, Wang H, Liao Q, Zhou Y, Gong Q, Xiang B, Zhou M, Li X, Li G, Xiong W, Fang J, Zeng Z. Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal carcinoma. Cancer Lett. 2020 May 1;477:131-143. PMID: 32061950 （IF: 7.360）（曾朝阳，熊炜组）
24. Li T, Mao C, Wang X, Shi Y, Tao Y. Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation. Journal of Experimental & Clinical Cancer Research. 2020;39(1):224. PMID: 33109235 （IF: 7.068）（陶永光组）
25. Niu W, Luo Y, Zhou Y, Li M, Wu C, Duan Y, Wang H, Fan S, Li Z, Xiong W, Li X, Li G, Ren C, Li H, Zhou M. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research. 2020 Feb 7;39(1):30. PMID: 32028981 （IF: 7.068）（周鸣，任彩萍组）
26. Liu C, Peng Z, Li P, Fu H, Feng J, Zhang Y, Liu T, Liu Y, Liu Q, Liu Q, Li D, Wu M. LncRNA RMST Suppressed GBM Cell Mitophagy through Enhancing FUS SUMOylation. Mol Ther Nucleic Acids. 2020;19:1198-1208. PMID: 32069702 （IF: 7.032）（武明花组）
27. Liu Y, Mao C, Wang M, Liu N, Ouyang L, Liu S, Tang H, Cao Y, Liu S, Wang X, Xiao D, Chen C, Shi Y, Yan Q, Tao Y. Cancer progression is mediated by proline catabolism in non-small cell lung cancer. Oncogene. 2020, 39(11):2358-2376. PMID: 31911619 （IF: 6.634）（陶永光组）
28. Xia J, He Y, Meng B, Chen S, Zhang J, Wu X, Zhu Y, Shen Y, Feng X, Guan Y, Kuang C, Guo J, Lei Q, Wu Y, An G, Li G, Qiu L, Zhan F, Zhou W. NEK2 induces autophagy-mediated bortezomib resistance by stabilizing Beclin-1 in multiple myeloma. Molecular Oncology. 2020;14(4): 763-778. PMID: 31955515 （IF: 6.574）（周文组）
29. Tang T, Yang L, Cao Y, Wang M, Zhang S, Gong Z, Xiong F, He Y, Zhou Y, Liao Q, Xiang B, Zhou M, Guo C, Li X, Li Y, Xiong W, Li G, Zeng Z. LncRNA AATBC regulates Pinin to promote metastasis in nasopharyngeal carcinoma. Molecular Oncology. 2020,14:2251-2270. PMID: 32364663 （IF: 6.574）（曾朝阳组）
30. Wei F, Wang D, Wei J, Tang N, Tang L, Xiong F, Guo C, Zhou M, Li X, Li G, Xiong W, Zhang S, Zeng Z. Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance. Cell Mol Life Sci. 2021 Jan;78(1):173-193. PMID: 32654036 （IF: 6.496）（曾朝阳组）
31. Shi F, He Y, Li J, Tang M, Li Y, Xie L, Zhao L, Hu J, Luo X, Zhou M, Liu N, Fan J, Zhou J, Gao Q, Qiu S, Wu W, Zhang X, Jia W, Bode AM, Cao Y. Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis. Molecular Metabolism. 2020 Jun;36:100966. PMID: 32224436 （IF: 6.448）（曹亚组）
32. He W, Kang Y, Zhu W, Zhou B, Jiang X, Ren C, Guo W. FOXF2 acts as a crucial molecule in tumours and embryonic development. Cell Death Dis. 2020 Jun 5;11(6):424. PMID: 32503970 （IF: 6.304）（任彩萍组）
33. Yang Y, He C, E. Dianyu, Yang W, Qi F, Xie D, Shen L, Peng S, Shuai C. Mg bone implant: features, developments and perspectives. Mater Design. 2020, Jan5,185(5)108259.（IF: 6.289）（彭淑平，帅词俊组）
34. Zang M, Guo J, Liu L, Jin F, Feng X, An G, Qin X, Wu Y, Lei Q, Meng B, Zhu Y, Guan Y, Deng S, Hao M, Xu Y, Zou D, Wu M, Qiu L, Zhou W. Cdc37 suppression induces plasma cell immaturation and bortezomib resistance in multiple myeloma via Xbp1s. Oncogenesis. 2020;9(3): 31-44. PMID: 32139666 （IF: 6.119）（周文组）
35. Cao L, Liu W, Zhong Y, Zhang Y, Gao D, He T, Liu Y, Zou ZMo Y, Peng S, Shuai C. Linc02349 promotes osteogenesis of human umbilical cord-derived stem cells by acting as a competing endogenous RNA for miR-25-3p and miR-33b-5p. Cell Proliferat. 2020 May;53(5):e12814. PMID: 32346990 （IF: 5.753）（彭淑平组）
36. Wu X, Xia J, Zhang J, Zhu Y, Wu Y, Guo J, Chen S, Lei Q, Meng B, Kuang C, Feng X, He Y, Shen Y, Li X, Qiu L, Li G, Zhou W. Phosphoglycerate dehydrogenase promotes proliferation and bortezomib resistance through increasing reduced glutathione synthesis in multiple myeloma. British journal of haematology. 2020;190(1):52-66. PMID: 32037523 （IF: 5.518）（李官成，周文组）
37. Zhang M ,Liang L, He J, He Z, Yue C, Jin X, Gao M, Xiao S, Zhou Y. Fra-1 Inhibits Cell Growth and the Warburg Effect in Cervical Cancer Cells via STAT1 Regulation of the p53 Signaling Pathway. Front Cell Dev Biol. 2020 Sep 30;8:579629. PMID: 33102485 （IF: 5.201）（周艳宏组）
38. Wei J, Wu C, Meng H, Li M, Niu W, Zhan Y, Jin L, Duan Y, Zeng Z, Xiong W, Li G, Zhou M. The biogenesis and roles of extrachromosomal oncogene involved in carcinogenesis and evolution. Am J Cancer Res. 2020;10(11). PMID: 33294253 （IF: 5.177）（周鸣组）
39. Li Z, Zhou Z, Wu X, Zhou Q, Liao C, Liu Y, Li D, Shen L, Feng D, Yang L. LMP1 promotes nasopharyngeal carcinoma metastasis through NTRK2-mediated anoikis resistance. Am J Cancer Res. 2020, 10(7): 2083–2099. PMID: 32775002 （IF: 5.177）（杨力芳组）
40. Zou Z, Liu W, Cao L, Liu Y, He T , Peng S, Shuai C. Advances in the Occurrence and Biotherapy of Osteoporosis, Biochemical Society Transactions. Biochem Soc Trans. 2020 Aug 28;48(4):1623-1636. PMID: 32627832 （IF: 5.160）（彭淑平组）
41. Zhou B, Yuan Y, Zhang S, Guo C, Li X, Li G, Xiong W, Zeng Z. Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract. Cellular and Molecular Life Sciences. 2020.7. PMID: 32318067 （IF: 5.085）（曾朝阳组）
42. Wang D, Zeng Z, Zhang S, Xiong F, He B, Wu Y, Li W, Tang L, Wei F, Xiang B, Li Z, Zhou Y, Zhou M, Li X, Li Y, Li G, Xiong W, Guo C. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis. FASEB JOURNAL. 2020 Jun;34(6):8012-8027. PMID: 32306460 （IF: 4.966）（熊炜组）
43. Wu Y, Wang D, Wei F, Xiong F, Zhang S, Gong Z, Shi L, Li X, Xiang B, Ma J, Deng H, He Y, Liao Q, Zhang W, Li X, Li Y, Guo C, Zeng Z, Li G, Xiong W. EBV-miR-BART12 accelerates migration and invasion in EBV-associated cancer cells by targeting tubulin polymerization-promoting protein 1. The FASEB Journal. 2020 Dec;34(12):16205-16223. PMID: 33094864 （IF: 4.966）（熊炜组）
44. Liao C, Zhou Q, Zhang Z, Wu X, Zhou Z, Li B, Peng J, Shen L, Li D, Luo X, Yang L. EBV-LMP1 promotes extracellular vesicle secretion via SDC2 and SYTL4 in nasopharyngeal carcinoma cells. Cancer Sci. 2020, 111(3):857-868.（IF: 4.966）（杨力芳组）
45. Shuai C, Zan J, Yang Y, Peng S, Yang W, Qi F, Shen L, Tian Z. Surface modification enhances interfacial bonding in PLLA/MgO bone scaffold. Mat Sci Eng C-Mater. 2020,108:110486. PMID: 31924055 （IF: 4.959）（彭淑平组）
46. He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci. 2020 Jul 19;16(14):2628-2647. PMID: 32792861 （IF: 4.858）（陶永光组）
47. Zhong Y, Cao L, Ma H, Wang Q, Wei P, Yang J, Mo Y, Cao L, Shuai C, Peng S. Lin28A regulates stem-like properties of ovarian cancer cells by enriching RAN and HSBP1 mRNA and up-regulating its protein expression. Int J Biol Sci. 2020 Apr 15; 16(11): 1941-1953. PMID: 32398961 （IF: 4.858）（彭淑平组）
48. Zheng L, Xu J, Sai B, Zhu Y, Wang L, Yin N, Yu F, Zhou W, Wu M, Tang J, Xiang J. Microbiome related Cytotoxically active CD8+ TIL are inversely associated with lung cancer development. Frontiers in oncology. 2020 Dec 9;10:531131. PMID: 33363002 （IF: 4.848）（向娟娟组）
49. Yin W, Jiang X, Tan J, Xin Z, Zhou Q, Zhan C, Fu X, Wu Z, Guo Y, Jiang Z, Ren C, Tang G. Development and Validation of a Tumor Mutation Burden-Related Immune Prognostic Model for Lower-Grade Glioma. Front Oncol. 2020 Aug. PMID: 32974146 （IF: 4.848）（任彩萍组）
50. Zhao C, She X, Zhang Y, Liu C, Li P, Chen S, Sai B, Li Y, Feng J, Liu J, Sun Y, Xiao S, Li L, Wu M. LRRC4 Suppresses E-Cadherin-Dependent Collective Cell Invasion and Metastasis in Epithelial Ovarian Cancer. FrontOncol. 2020;14;10:144. PMID: 32117780 （IF: 4.848）（武明花组）
51. He Z, Duan Z, Chen L, Li B, Zhou Y. Long non-coding RNA Loc490 inhibits gastric cancer cell proliferation and metastasis by upregulating RNA-binding protein Quaking. Aging (Albany NY). 2020 Sep 15;12(17):17681-17693. PMID: 32931453 （IF: 4.831）（周艳宏组）
52. Li Z, Wang J, Zhang X, Liu P, Zhang X, Wang J, Zheng X, Wei L, Peng Q, Liu C,Yan Q, Shen S, Li X, Ma J. Proinflammatory S100A8 Induces PD-L1 Expression in Macrophages, Mediating Tumor Immune Escape. Journal of Immunology. 2020 May 1;204(9):2589-2599. PMID:32198140 （IF: 4.718）（马健组）
53. Wang L, Chen A, She X, Xiang J, Tang J. VPS41-BRAF, a novel BRAF fusion gene identified in a lung adenocarcinoma patient by next-generation sequencing. Lung Cancer. 2020 Aug;146:380-381. PMID: 32527614 （IF: 4.702）（向娟娟组）
54. Fan C, Zhang S, Gong Z, Li X, Xiang B, Deng H, Zhou M, Li G, Li Y, Xiong W, Zeng Z, Li X. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy. Sci China Life Sci. 2020 Aug 17. PMID: 32815067 （IF: 4.611）（曾朝阳组）
55. Cai J, Chen S, Yi M, Tan Y, Peng Q, Ban Y, Yang J, Li X, Zeng Z, Xiong W, McCarthy JB, Li G, Li X, Xiang B. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma. Carcinogenesis. 2020 Sep 24;41(9):1282-1293. PMID: 31826234 （IF: 4.608）（向波组）
56. Chen S, Youhong T, Tan Y, He Y, Ban Y, Cai J, Li X, Xiong W, Zeng Z, Li G, Yi M, Liu W, Xiang B. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2. Carcinogenesis. 2020 Jul 10;41(6):723-733. PMID: 31665243 （IF: 4.608）（向波组）
57. Liao C, Li M, Li X, Li N, Zhao X, Wang X, Song Y, Quan J, Cheng C, Liu J, Bode AM, Cao Y, Luo X. Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158540. PMID: 31678511 （IF: 4.519）（罗湘建组）
58. Liu H, Li S, Ren C, Liu W, Zhu B, Wang L, Xu H, Xie W, Zuo X, Zhou Y, Luo L, Jiang X. Generation of an ESRG Pr-tdTomato reporter human embryonic stem cell line, CSUe011-A, using CRISPR/Cas9 editing. STEM CELL RESEARCH. 2020 Oct. PMID: 32919352 （IF: 4.495）（任彩萍组）
59. Peng Q, Wang L, Qin Z, Wang J, Zheng X, Wei L, Zhang X, Zhang X, Liu C, Li Z, Wu Y, Li G, Yan Q, Ma J. Phase separation of Epstein-Barr Virus EBNA2 and Its Coactivator EBNALP controls gene expression. Journal of Virology. 2020; 94(7): e01771-19. PMID: 31941785 （IF: 4.368）（马健组）
60. Sun R, Wang R, Chang S, Li K, Sun R, Wang M, Li Z. Long non-coding RNA in drug resistance of non-small cell lung cancer: A Mini Review. Frontiers in Pharmacology. 2019; 10: 1457. PMID: 31920650 （IF: 4.225）（李征组）
61. Li L, Liu S, Han D, Bin Tang B, Ma J. Delivery and biosafety of oncolytic virotherapy. Frontiers in Oncology. 2020 Apr 16;10:475. PMID: 32373515 （IF: 4.137）（马健组）
62. Shuai C, Liu G, Yang Y, Yang W, He C, Wang G, Liu Z, Qi F, Peng S. Functionalized BaTiO3 enhances piezoelectric effect towards cell response of bone scaffold. Colloid Surface B. 2020,185:110587. PMID: 31648118 （IF: 3.973）（彭淑平组）
63. Zhu Y, Shi C, Zeng L, Liu G, Jiang W, Zhang X, Chen S, Guo J, Jian X, Ouyang J, Xia J, Kuang C, Fan S, Wu X, Wu Y, Zhou W, Guan YJ. High COX‐2 expression in cancer-associated fibroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma. Molecular Carcinogenesis. 2020 Mar; 59(3):265-280. PMID: 31867776 （IF: 3.825）（周文组）
64. Wang F, Zhang L, Sai B, Wang L, Zhang X, Zheng L, Tang J, Li G, Xiang J. BMSC-derived leptin and IGFBP2 promote erlotinib resistance in lung adenocarcinoma cells through IGF-1R activation in hypoxic environment. Cancer Biol Ther. 2020;21(1):61-71. PMID: 31559898 （IF: 3.659）（向娟娟组）
65. Wang L, Peng Q, Sai B, Zheng L, Xu J, Yin N, Feng X, Xiang J. Ligand-independent EphB1 signaling mediates TGF-β-activated CDH2 and promotes lung cancer cell invasion and migration. J Cancer. 2020 Apr 7;11(14):4123-4131.PMID: 32368295 （IF: 3.565）（向娟娟组）
66. Ge J, Wang J, Wang H, Jiang X, Liao Q, Gong Q, Mo Y, Li X, Li G, Xiong W, Zhao J, Zeng Z. The BRAF V600E mutation is a predictor of the effect of radioiodine therapy in papillary thyroid cancer. Journal of Cancer. 2020:11-4:932-939. PMID: 31949496 （IF: 3.565）（曾朝阳组）
67. Xie H, Liu S, Zhang Z, Chen P, Tao Y. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma. J Cancer. 2020 Jul. PMID: 32913470 （IF: 3.565）（陶永光组）
68. Peng Q, Zhang L, Li J, Wang W, Cai J, Ban Y, Zhou Y, Hu M, Mei Y, Zeng Z, Li X, Xiong W, Li G, Tan Y, Xiang B, Yi M. FOXA1 Suppresses the Growth, Migration, and Invasion of Nasopharyngeal Carcinoma Cells through Repressing miR-100-5p and miR-125b-5p. J Cancer. 2020; 11(9):2485-2495. PMID: 32201519 （IF: 3.565）（向波组）
69. Liu J, Wu Q, Shi J, Guo W, Jiang X, Zhou B, Ren C. LILRB4, from the immune system to the disease target. Am J Transl Res. 2020 Jul 15;12(7):3149-3166. PMID: 32774691 （IF: 3.375）（任彩萍组）
70. Gao F, Fan Y, Zhou B, Guo W, Jiang X, Shi J, Ren C. The functions and properties of cullin-5, a potential therapeutic target for cancers. Am J Transl Res. 2020 Feb 15;12(2):618-632. PMID: 32194910 （IF: 3.375）（任彩萍组）
71. Cheng C, Li Z, Zhao X, Liao C, Quan J, Bode AM, Cao Y, Luo X. Natural alkaloid and polyphenol compounds targeting lipid metabolism: Treatment implications in metabolic diseases. Eur J Pharmacol. 2020 Mar 5;870:172922. PMID: 31935398 （IF: 3.263）（罗湘建组）
72. Liu P, Zhang X, Li Z, Wei L, Peng Q, Liu C, Wu Y, Yan Q, Ma J. A Significant Role of Transcription Factors E2F in Inflammation and Tumorigenesis of Nasopharyngeal Carcinoma. Biochemical and Biophysical Research Communications. 2020; 524(4): 816-824. PMID: 32044038 （IF: 2.705）（马健组）
73. He T, Liu W, Cao L, Liu Y, Zou Z, Zhong Y, Wang H, Mo Y, Peng S, Shuai C. CircRNAs and LncRNAs in Osteoporosis. Differentiation. 2020 Oct 28;116:16-25. PMID: 33157509 （IF: 2.392）（彭淑平组）
74. Shuai C, Li Y, Deng F, Yang Y , Peng S, Qi F, Shen L. Mesoporous Carbon as Galvanic-Corrosion Activator Accelerates Fe Degradation. Appl Sci. 2020, 10, 2487; doi:10.3390/app10072487.（IF: 2.217）（彭淑平组）
75. Zhu W, Zhou BL, Rong LJ, Ye L, Xu HJ, Zhou Y, Yan XJ, Liu WD, Zhu B, Wang L, Jiang XJ, Ren CP. Roles of PTBP1 in alternative splicing, glycolysis, and oncogensis. J Zhejiang Univ Sci B. 2020 Feb.;21(2):122-136. PMID: 32115910 （IF: 2.082）（任彩萍组）
76. Shuai C, Wang C, Qi F, Peng S, Yang W, He C, Wang G, Qian G. Enhanced crystallinity and anti-bacterial of PHBV scaffolds incorporated with zinc oxide. Journal of Nanomaterials. https://doi.org/10.1155/2020/6014816.（IF: 1.980）（彭淑平组）
77. Cai J, Liu C, Yi M, Tan Y, Chen S, Ren N, Cheng H, Li X, Xiong W, Li G, Wu M, Wang W, Xiang B. The tumor suppressor NOR1 suppresses cell growth, invasiveness and tumorigenicity in Glioma. Neoplasma. 2020; 67(4): 851-860. PMID: 32241159 （IF: 1.721）（向波组）
78. Gao M, He Y, Tang H, Chen X, Liu S, Tao Y. cGAS/STING: novel perspectives of the classic pathway. Molecular Biomedicine. 2020 Sep 20, 1(1): 7.（陶永光组）
79. Wu T, Hu E, Zeng W, Zhang H, Xue X, Ma J. Unprecedented action has been taken to contain the epidemic of COVID-19 in China. 中南大学学报医学版. 2020; 45(3): 334-337（马健组）
